España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Design Therapeutics
DSGN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Design Therapeutics (DSGN) Forecast
News
Earnings
Design Therapeutics (DSGN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Design Therapeutics (NASDAQ:DSGN) Stock
Design Therapeutics Stock (NASDAQ: DSGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 07, 2024
Design Therapeutics Q3 2024 GAAP EPS $(0.23) ...
Benzinga Newsdesk
Tuesday, August 06, 2024
RBC Capital Reiterates Sector Perform on Desi...
Benzinga Newsdesk
Monday, August 05, 2024
Design Therapeutics Q2 EPS $(0.21) Beats $(0....
Benzinga Newsdesk
Wednesday, May 08, 2024
Design Therapeutics Q1 EPS $(0.20) Beats $(0....
Benzinga Newsdesk
Tuesday, May 07, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Design Therapeutics shares are trading higher...
Benzinga Newsdesk
Piper Sandler Upgrades Design Therapeutics to...
Benzinga Newsdesk
Tuesday, March 26, 2024
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
Avi Kapoor
Wednesday, March 20, 2024
RBC Capital Reiterates Sector Perform on Desi...
Benzinga Newsdesk
Wedbush Reiterates Neutral on Design Therapeu...
Benzinga Newsdesk
Tuesday, March 19, 2024
Design Therapeutics Outlines Progress Across GeneTAC Platform
Happy Mohamed
Design Therapeutics Q4 EPS $(0.21) Beats $(0.31) Estimate
Happy Mohamed
Earnings Scheduled For March 19, 2024
Benzinga Insights
Monday, March 18, 2024
Earnings Preview For Design Therapeutics
Benzinga Insights
Friday, February 09, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Tuesday, November 14, 2023
RBC Capital Maintains Sector Perform on Desig...
Benzinga Newsdesk
Monday, November 13, 2023
Design Therapeutics Q3 EPS $(0.28) Beats $(0....
Benzinga Newsdesk
Thursday, September 07, 2023
Director At This Health Care Company Buys $14.00M of Stock
Benzinga Insights
Wednesday, September 06, 2023
President at Design Therapeutics Acquires Company Stock Options Worth 2,100,000 Shares
Benzinga Insights
Thursday, August 31, 2023
Design Therapeutics Board Member Makes $5.37M Stock Purchase
Benzinga Insights
Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Lisa Levin
Tuesday, August 22, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, August 17, 2023
Market Sentiment Teeters As US Indices, Including S&P 500, Break Key Supports: Next Levels To Watch
Piero Cingari
Tuesday, August 15, 2023
Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments
Vandana Singh
Nasdaq Falls 100 Points; Siyata Mobile Shares Spike Higher
Lisa Levin
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Crude Oil Down 2%; Home Depot Posts Upbeat Earnings
Lisa Levin
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
Benzinga Insights
Dow Falls Over 200 Points; US Retail Sales Top Expectations
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Why Is Design Therapeutics Stock Moving Lower Today?
Vandana Singh
Design Therapeutics shares are trading lower ...
Benzinga Newsdesk
Wedbush Downgrades Design Therapeutics to Neu...
Benzinga Newsdesk
SVB Leerink Downgrades Design Therapeutics to...
Benzinga Newsdesk
Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket
Lisa Levin
RBC Capital Downgrades Design Therapeutics to...
Benzinga Newsdesk
Design Therapeutics, Getty Images, Sea Limited And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Lisa Levin
Monday, August 14, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Design Therapeutics Q2 EPS $(0.36) Beats $(0....
Benzinga Newsdesk
Design Therapeutics Reports Initial Results F...
Benzinga Newsdesk
Friday, July 28, 2023
Shares of companies with Friedrich's Ataxia c...
Benzinga Newsdesk
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated
Vandana Singh
Tuesday, June 27, 2023
Why American Equity Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Friday, May 26, 2023
Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Wednesday, May 10, 2023
RBC Capital Maintains Outperform on Design Th...
Benzinga Newsdesk
Wedbush Maintains Outperform on Design Therap...
Benzinga Newsdesk
Tuesday, May 09, 2023
Design Therapeutics Q1 EPS $(0.35) Beats $(0....
Benzinga Newsdesk
Thursday, May 04, 2023
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Benzinga Insights
Goldman Sachs Upgrades Design Therapeutics to...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch